In the present study, Amh was found to be abundantly expressed in the granulosa cells of
the primary growth follicles, and Amhr2 in the granulosa cells, oogonia and phase I oocytes …

Background Previous studies have investigated the effects of anti-Müllerian hormone (AMH)
and AMH type II receptor (AMHR2) polymorphisms on ovarian stimulation outcomes, but the …

Pharmacogenomics is a promising approach in the field of individualized medicine in in vitro
fertilization (IVF) treatment that aims to develop optimized pharmacotherapy depending on …

Background/Aims: Reported associations of reproductive outcomes (RO) and polycystic
ovary syndrome (PCOS) with genotypes of the Ile49Ser and-482A> G polymorphisms in the …

The aim of this study was to examine the effects of single-nucleotide polymorphisms (SNPs)
in the anti-Müllerian hormone (AMH) and AMH type II receptor (AMHRII) genes on in vitro …

Background: Infertility is a global burden and has become exceedingly common in the
preceding years; controlled ovarian stimulation (COS) is a pre-requisite for couples opting to …

Ovarian hyperstimulation syndrome (OHSS) is an undesirable complication in the course of
ovarian stimulation. This kind of stimulation is aimed at acquiring a sufficient number of high …

Objective To provide an update on single-gene mutations identified as causative for
pathologic diminished ovarian reserve (DOR) to inform clinical screening recommendations …

Background Infertile women may have underlying genetic abnormalities. There is, at
present, a significant number of studies on the relation between the follicle stimulating …

This systematic review evaluated whether single nucleotide polymorphisms of AMH and
AMHRII genes are associated with ovarian function. A literature search of PubMed and …